Hormonal and Metabolic Treatment for Pulmonary Hypertension

Hormonal, Metabolic, and Signaling Interactions in PAH

Recruiting Observational Study
Idiopathic Pulmonary Arterial Hypertension Heritable Pulmonary Arterial Hypertension Scleroderma Associated Pulmonary Arterial Hypertension Appetite Suppressant Associate PAH
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
Up to 90
Sex
Any
Study type
Observational
Participants needed
1,899 (estimated)
Sponsor
Vanderbilt University Medical Center · Other
Who this trial is looking for

This trial is looking for people with certain types of pulmonary hypertension, including those with family members affected by it. Participants will undergo tests and provide blood samples to help understand the disease better.

Are You a Good Fit for This Trial?

You may be able to join if

  • I have been diagnosed with idiopathic pulmonary arterial hypertension
  • I have been diagnosed with heritable pulmonary arterial hypertension
  • I have been diagnosed with associated pulmonary arterial hypertension
  • I am a family member of someone with this condition
  • I am aged between 0 and 90
  • I can easily get to the clinic for testing
  • I can tolerate fasting before my tests

You may not be able to join if

  • I have another diagnosis
  • I am older than 90
  • I am younger than 12 for skin biopsy
  • I have difficulty reaching the clinic for testing
  • I cannot tolerate fasting before my tests
  • I am younger than 7 for some parts of the study

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial

Our hypothesis is that optimal treatment of the dysfunctional metabolic pathways which underlie PAH will improve pulmonary vascular function and consequences of the disease.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: Project 1 Inclusion: 1. Diagnosis of IPAH (idiopathic pulmonary arterial hypertension), HPAH (heritable pulmonary arterial hypertension), or APAH (associated pulmonary arterial hypertension), family members of affected persons 2. Age 0-90, age 12-90 for skin biopsy Exclusion:…
Contacts

Kelly L Fox

800-288-0378

Kelly.Burke@vumc.org

CONTACT

Shannon Cordell, BSN

615-343-8277

shannon.eason@vumc.org

CONTACT